| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6189298 | Brachytherapy | 2014 | 13 Pages |
Abstract
Consistently high local tumor control and low complications rates are reported with HDR monotherapy. It provides reproducible high-quality dosimetry, it has an advantage from a radiobiology perspective, and it has a good radiation safety profile. HDR brachytherapy is a safe and effective local treatment modality for prostate cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
D. Jeffrey Demanes, Michel I. Ghilezan,